Arthur Kavanaugh is Professor of Medicine at the University of California, San Diego School of Medicine. In addition, he is the Director of the Center for Innovative Therapy in the UCSD Division of Rheumatology, Allergy, and Immunology. Dr Kavanaugh has authored more than 400 publications. He is on the editorial board for several journals, and has served as peer reviewer for many scientific journals. Dr Kavanaugh’s main research interest is in clinical research, particularly translational aspects of rheumatology research. PP Tak, DM Gerlag, KR Aupperle, DA Van De Geest, M Overbeek. Arthritis & Rheumatology 44 (8), 1897-1907, 2001. Synovial interleukin‐1 receptor antagonist and interleukin‐1 balance in rheumatoid arthritis. GS Firestein, DL Boyle, C Yu, MM Paine, TD Whisenand, NJ Zvaifler. Arthritis & Rheumatology 37. Kenneth Kalunian is the Associate Director of the Center for Innovative Therapy and also a Professor in the Division of Rheumatology, Allergy and Immunology in. Join your colleagues for key updates in internal medicine research. Division of Rheumatology. The University of California, San Diego School of Medicine. This has included work delineating the pathophysiology of rheumatic diseases as well as defining changes associated with novel immunomodulatory therapies. The focus of many clinical projects has been RA and psoriatic arthritis, but Dr Kavanaugh has conducted many studies in other autoimmune conditions, including SLE, ankylosing spondylitis, inflammatory bowel disease, and others. In addition, he has performed studies focusing on novel imaging methods and also clinical outcomes. Follow him on Twitter @RWCSmtg. Update on Psoriatic Arthritis and Ankylosing Spondylitis Arthur F. Kavanaugh, MD: 10:15 am: Break. Official website of the University of California, San Diego. Dear Colleague. Rheumatologists have witnessed many exciting and important developments in the diagnostic and therapeutic approaches to patients with rheumatologic disorders. For well over a decade, greater understanding of the immunologic basis of autoimmune disorders has resulted in the introduction of targeted.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
July 2018
Categories |